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Abstract
Importance—It is unclear if helping patients meet resource needs, such as difficulty affording 
food, housing, or medications, improves clinical outcomes.
Objective—To determine the effectiveness of the Health Leads (HL) program on improvement in 
systolic and diastolic blood pressure (SBP, DBP; units: mm Hg), low-density lipoprotein 
cholesterol (LDL-C; units: mg/dL), and hemoglobin A1c (HbA1c).
Design—Difference-in-difference evaluation of HL from October 1, 2012 through September 30, 
2015. HL consists of screening for unmet needs at clinic visits, and offering those who screen 
positive to meet with an ‘advocate’ to help obtain resources, or receive brief information provision.
Setting—Three academic primary care practices
Participants—5125 people screened, using a standardized form, for unmet basic resource needs
Main Outcome(s) and Measure(s)—Changes in SBP, DBP, LDL-C, and HbA1c. We 
compared those who screened positive for unmet basic needs (HL group) to those who screened 
negative, using intention-to-treat, and, secondarily, between those who did and did not enroll in 
HL, using linear mixed modeling, examining the period before and after screening.
Results—Of 5125 people screened, 1774 (35%) reported at least one unmet need, and 58% of 
those enrolled in HL. Median follow-up for those who screened positive and negative was 34 and 
32 months, respectively. In unadjusted intention-to-treat analyses of 1998 participants with 
hypertension, the HL group experienced greater reduction in SBP (differential change −1.2 95% 
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Confidence Interval [CI] −2.1 to −0.4) and DBP (differential change −1.0 95% CI −1.5 to −0.5). 
For 2281 individuals with an indication for LDL-C lowering, results also favored the HL group 
(differential change −3.7, 95%CI −6.7 to −0.6). For 774 individuals with diabetes, the HL group 
did not show HbA1c improvement (differential change −0.04% 95%CI −0.17% to 0.10%). Results 
adjusted for baseline demographic and clinical differences were not qualitatively different. Among 
those who enrolled in HL program, there were greater BP and LDL-C improvements then for 
those who declined (SBP differential change −2.6 95%CI −3.5 to −1.7; SBP differential change 
−1.4 95%CI −1.9 to −0.9; LDL-C differential change −6.3 95%CI −9.7 to −2.8).
Conclusions and Relevance—Screening for and attempting to address unmet basic resource 
needs in primary care was associated with modest improvements in blood pressure and lipid, but 
not blood glucose, levels.
Keywords
Food Insecurity; Health Expenditures; Socioeconomic Status; Diabetes; Cardiovascular Disease; 
Hypertension
Chronic cardiometabolic diseases, such as hypertension, diabetes, and lipid disorders, are 
leading causes of morbidity and mortality in the U.S.1, 2 The connection between poor 
outcomes in these conditions and unmet resource needs, such as difficulty affording food, 
housing, and medications, has become increasingly clear.3–17 This has led to interest in 
programs that seek to ‘link’ patients identified in clinical care sites as having unmet basic 
resource needs to community-based resources.18 This interest is exemplified by the recent 
Accountable Health Communities (AHC) model proposed by the Centers for Medicare & 
Medicaid Services (CMS)3. Specifically, interventions to screen for unmet needs and link 
patients to community resources in order to address them are at the heart of Track 2 and 
Track 3 of the AHC model.3
Despite growing interest and intuitive appeal, there is as yet scant evidence to support the 
effectiveness of ‘linkage’ interventions for improving cardiometabolic disease control. To 
help understand the potential of linkage interventions in chronic cardiometabolic disease 
management, we conducted a pragmatic evaluation of the Health Leads program in three 
primary care practices.19 The Health Leads program includes screening for unmet resource 
needs, an assessment of those who report these needs, and assignment to an ‘advocate’, who 
then works with a patient to receive resources and benefits to meet those needs.19 For 
example, a patient who reports difficulty affording food could be assisted with enrollment in 
the Supplemental Nutrition Assistance Program (SNAP). Conceptually, such assistance 
could enhance and make more effective the routine care being delivered to patients. For 
example, addressing transportation issues could enable patients to attend a greater 
proportion of clinic appointments, and assisting with medication affordability could enable 
patients to adhere to their treatment plan more closely. Therefore, we hypothesized that 
participation in the Health Leads program would be associated with improvements in key 
indicators of cardiometabolic disease management: blood pressure, low density lipoprotein 
cholesterol (LDL-C) and Hemoglobin A1c (HbA1c) control.
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Setting and Study Participants
We conducted a pragmatic evaluation of the Health Leads program in three academic adult 
(age > 18 years) internal medicine practices within a primary care network in the Boston 
metropolitan area. Patients who presented for routine care completed screening for unmet 
basic resource needs at visit check-in. All who completed screening between October 1, 
2013 (when the program began in the clinics) and April 30, 2015 were included in the study. 
Electronic health record data for participants were obtained from October 1, 2012 (i.e. at 
least 1 year prior to screening) through September 30, 2015 (i.e. at least 5 months after 
screening).
The Health Leads program was implemented as the standard of care during the study period, 
therefore, the Human Research Committee at Partners Health Care approved this analysis of 
usual care data with a waiver of the informed consent requirement.
Screening and Intervention
The Health Leads program has been described in detail elsewhere.19 In brief, patients 
complete a standardized screening form that allowed the patient to self-identify unmet 
resource needs related to food, medications, transportation, utilities, employment, elder care 
services and housing. Patients who report unmet needs are referred to program staff to 
complete an assessment and determine if the patient should be enrolled in the program or 
receive a “rapid resource referral”, which consisted of one-time provision of information. 
Patients who choose to enroll in the program are assigned to an ‘advocate’, usually an 
undergraduate student volunteer, operating under the supervision of professional program 
staff, who works with the patient to prioritize unmet basic resource needs, identify 
community resources and/or public benefits to meet them, and facilitate receipt of those 
resources and/or benefits. Each situation had standardized guidelines to indicate when a case 
could be closed with one of three resolution types: (1) benefits had been received 
(‘successful’), (2) the need was met elsewhere, could not be met or the advocate lost contact 
with the patient (‘unsuccessful’), or (3) the patient indicated they were able to move forward 
without continued assistance (‘equipped’).19 As an example, if a patient reported a food 
need, and was eligible for but not enrolled in SNAP, the advocate would work with the 
participant until they were enrolled and benefits were available on an electronic benefit 
transfer card.19
Outcomes
Our primary outcome was systolic blood pressure (SBP) trend, as it is the most common 
cardiometabolic risk factor, and is strongly associated with morbidity and mortality.20 Our 
secondary outcomes were diastolic blood pressure (DBP), LDL-C, and HbA1c. These 
outcomes are targeted for clinical management in adults with pre-existing cardiometabolic 
diseases. Therefore, for blood pressure outcomes we included those individuals with a 
history of hypertension. Similarly, for analyses of LDL-C, participants had a diagnosis of 
hypertension, coronary heart disease, chronic kidney disease, or diabetes mellitus. For 
analyses of HbA1c, we included participants with diabetes mellitus. These diagnoses were 
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assessed at time of screening, and were determined using previously validated electronic 
health record algorithms, which have been used in prior studies (validation documents 
available upon request).19, 21, 22 Outcome data were collected as part of routine clinical care. 
Just as patients often qualify for more than one clinical performance metric, participants 
could be included in the analysis of more than one outcome (e.g. a participant with diabetes 
and hypertension would be included in the analyses of SBP, DBP, LDL-C, and HbA1c).
We also considered several covariates that may influence the trend in study outcomes. Age, 
gender, race/ethnicity, educational attainment, health insurance, primary language, clinical 
conditions, and comorbidity as indicated by the Charlson comorbidity score were abstracted 
from the electronic health record and adjusted for in our analyses.19
Statistical Analysis
We first performed descriptive statistics. Given that the Health Leads program had adequate 
capacity to serve all patients identified through screening in the three practices, there was no 
group of participants who completed screening but were not offered interventional services. 
Therefore, to test whether program referral was associated with improved health outcomes, 
we used a difference-in-difference approach. In this design, participants serve as their own 
controls by comparing trends in outcome before and after the intervention. Simultaneously, 
those who received care in the same practices during the same time, but screened negative 
for unmet resource needs, were used to account for ‘secular trends’: other occurrences, aside 
from the Health Leads program, that may have influenced the outcomes, such as on-going 
chronic disease management programs in the clinics. Our primary analyses compared those 
with one of the defined conditions who screened positive (regardless of whether they 
enrolled in the Health Leads program) to those with one of the defined conditions who 
screened negative for unmet resource needs. Analogous to an intention-to-treat analysis of a 
randomized controlled trial, this approach provides the best estimate of the real world 
effectiveness of the program. As secondary analyses, we also examined change in outcome 
trend by Health Leads participation category—comparing those who screened negative to 
those who screened positive but declined a referral to Health Leads, those who declined 
services after an initial interview with Health Leads, those who received only a ‘rapid 
resource referral’, and those who fully enrolled in the Health Leads program. The date of 
screening demarcated the pre- and post-intervention periods for both groups. Participants 
needed to have at least one outcome measurement in the pre- and post-period in order to be 
included in the main analyses, but we conducted sensitivity analyses that did not include this 
requirement. We analyzed the outcomes as continuous variables because blood pressure, 
LDL-C, and HbA1c have a linear association with poor health outcomes over most of their 
clinically relevant range23–25. As outcomes could be measured multiple times per participant 
and were not measured on a fixed schedule (‘unbalanced’ design) we used longitudinal 
mixed effects linear regression models for hypothesis testing, with patient level random 
effects to account for repeated measurements within patients. All observations of a particular 
parameter (e.g. blood pressure) were used for analysis. A p-value < 0.05 indicated statistical 
significance.
Analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).
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Overall, 5125 people were screened for unmet basic resource needs at the participating 
practices from October 1, 2013 to April 30, 2015 (Figure 1). Of these, 1774 (35%) screened 
positive for at least one unmet resource need. Of those who screened positive, they reported 
a median of 2 (25th percentile: 1; 75th percentile: 3) unmet needs. Overall, those reporting 
unmet resource needs were more likely to self-identify as a racial/ethnic minority, have less 
than high school diploma education, speak a primary language other than English, and have 
Medicaid insurance (Table 1).
Of those who screened positive, 58% (n=1021) enrolled in the Health Leads program, 14.6% 
(n=259) declined referral, and 17.0% (n=301) declined services after an initial interview. 
The most commonly reported needs were in the areas of healthcare, including medication 
affordability, utilities, and food. For those enrolled in Health Leads, cases were open for a 
median 42 days (25th percentile: 24; 75th percentile: 71), and participants received a median 
5 (25th percentile: 3; 75th percentile: 9) contacts from their advocate. Of those who discussed 
their needs with Health Leads, 29.7% of reported needs were closed as ‘successful’, 27.9% 
as ‘equipped’, 34.9% as ‘unsuccessful’ and 7.1% handled with a rapid resource referral. 
Almost all (93%) of the ‘unsuccessful’ category involved participants who stopped 
responding to attempts to contact them from Health Leads advocates.
For blood pressure analyses, 832 participants who screened positive and 1166 participants 
who screened negative met inclusion criteria (eTable 1). For LDL-C analyses, 967 
participants who screened positive and 1314 participants who screened negative were 
included. For HbA1c analyses, 452 participants who screened positive and 322 who 
screened negative were included. Those who screened positive represent the Health Leads 
group for the following analyses. Median time studied was 34 (25th percentile: 25; 75th 
percentile: 36) months for those who screened positive and 32 (25th percentile: 26; 75th 
percentile: 36) months for those who screened negative. Those who screened positive had a 
median time studied prior to screening of 17 (25th percentile: 11; 75th percentile: 26) 
months, and median time followed after screening of 12 (25th percentile: 7; 75th percentile: 
19) months. Those who screened negative had a median time studied prior to screening of 25 
(25th percentile: 18; 75th percentile: 28) months, and median time followed after screening 
of 6 (25th percentile: 6; 75th percentile: 8) months (eTable 2).
Of those with hypertension, baseline systolic blood pressure was slightly higher (133.1 mm 
Hg vs. 131.8 mm Hg, p=0.04) in the Health Leads group, but diastolic blood pressure was 
similar (76.6 mm Hg vs. 76.3 mm Hg, p =0.35) (Table 2). In unadjusted difference-in-
difference analyses, the differential change after screening favored the Health Leads group, 
with greater reduction in SBP (differential change −1.2 mm Hg 95% Confidence Interval 
[CI] −2.1 to −0.4 mm Hg) and DBP (differential change −1.0 mm/Hg 95% CI −1.5 to −0.5 
mm Hg) (Figure 2). In models adjusted for age, gender, race/ethnicity, educational 
attainment, primary language, health insurance, clinical conditions (diabetes, chronic kidney 
disease, coronary heart disease, cerebrovascular disease, and depression), and comorbidity 
score, the differential change again favored the Health Leads group (differential change in 
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SBP −1.6 mm Hg 95% CI −2.5 1 to −0.6 mm Hg; differential change in DBP −1.1 mm Hg 
95% CI −1.61 to −0.6 mm Hg).
For those with an indication for LDL-C lowering, baseline LDL-C was similar comparing 
the Health Leads group (103.0 mg/dL) to those who screened negative (100.2 mg/dL), p 
=0.14. Unadjusted difference-in-difference results again favored the Health Leads group 
(differential change −3.7 mg/dL, 95%CI −6.7 to −0.6 mg/dL) (Figure 2). Adjusted results 
were similar (differential change −3.9 mg/dL, 95%CI −7.2 to −0.6 mg/dL).
For those with diabetes, baseline HbA1c was greater in the Health Leads group compared 
with those who screened negative (7.53% vs. 7.19%, p=0.002). However, the Health Leads 
group did not see HbA1c improvement (differential change −0.04% 95%CI −0.17% to 
0.10%) (Figure 3). Adjusted results also revealed no differential improvement (0.03%, 
95%CI −0.12 to 0.17).
In secondary analyses based on program enrollment, rather than just screening positive for 
unmet needs, enrollment in Health Leads was associated with statistically significant benefit 
in SBP, DBP, and LDL-C reduction (Table 3). There remained no benefit for HbA1c 
reduction. The magnitude of these benefits was greater than the magnitude seen in the 
intention-to-treat analyses. Declining services, being lost to contact, or receiving a one-time 
referral to a resource were generally not associated with benefit.
Sensitivity analyses that did not require participants to have an outcome measurement in 
both the pre- and post-screening period were not substantially different from the main 
analyses (eTable 3). Information on health related quality of life in a subset of randomly 
selected participants (eTable 4), a ‘responder’ analysis of those with ‘out-of-control’ 
parameters that came under control in the post-intervention period (eTable 5), and a more 
detailed breakdown of presenting needs (eTable 6) is available in the supplemental material.
Discussion
In this study, we found that screening for unmet basic needs coupled with referral to a 
program that helped link patients to community resources and public benefits to meet those 
needs resulted in modest improvements in blood pressure and LDL-cholesterol, but not 
Hemoglobin A1c. These findings persisted even after adjustment for potential confounders. 
The association between intervention and blood pressure and cholesterol improvement was 
stronger for those who enrolled in the program, although this study cannot demonstrate 
causality.
This study is consistent with and extends our knowledge of healthcare interventions to 
address basic resource needs. While few other programs have focused specifically on unmet 
needs, several other strategies to address social determinants of health in clinic care have 
been tried, with variations in workforce (lay vs. professional), setting (clinic vs. community 
based), and on-going interaction (longitudinal empanelment vs. episodic engagement).26–36 
For example, community health worker programs often use a ‘lay’ workforce, based outside 
of the clinic, who work with specific patients over a long period of time.29 Alternatively, 
care coordination and case management programs are often based in clinics or healthcare 
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systems, and use professional staff, such as registered nurses or licensed clinical social 
workers.32, 35 Case management programs often feature longitudinal panels, while some 
social work referrals are more episodic in nature. Several of these approaches have achieved 
success for chronic disease management, although none focus specifically on unmet basic 
needs. This study presents an alternative model—lay clinic-based undergraduate volunteers, 
trained and equipped with tools to address episodic issues with basic resource needs—and 
finds that this approach can be successful.
The magnitude of the benefits in blood pressure and LDL-C improvement seen in this study 
may not be important clinically to an individual but are likely important at the population 
level, particularly considering that the results occurred in patient populations that typically 
benefit less from usual medical care, and that there is unlikely to be substantial harm from 
participation in the program. The reductions in blood pressure and LDL cholesterol seen in 
patients who enrolled in Health Leads are similar to those seen in a recent successful 
randomized control trial of a multi-faceted quality improvement intervention that did not 
focus on unmet basic resource needs.26 Further, a 2 mm Hg reduction in systolic blood 
pressure or a 1 mm Hg reduction in diastolic blood pressure is associated with an 
approximately 5% reduction in relative risk for coronary heart disease events.24 Similarly, a 
4 mmol/L reduction in LDL is associated with a 4% reduction in relative risk for coronary 
heart disease events.23
An unanswered question resulting from this study is why BP and LDL improved, while 
HbA1c did not. At this time, we are not sure why we observed this. Prior studies have 
established the importance of improving dietary quality, in addition to medication, in 
controlling hyperglycemia.37 The data in this study suggest that connections to resources to 
meet various needs (e.g. medication affordability and food) occur with equal success. 
However, the result of that connection may vary depending on the adequacy and efficacy of 
the ‘resource landscape’ available. For example, reducing financial barriers to medications 
(such as may occur if patients enroll in a pharmacy assistance program), is closely linked to 
improved adherence and improved health.12 However, connection to food resources, such as 
enrollment in SNAP or receipt of food from a food pantry, while effective for improving 
food insecurity, may not support the changes in dietary quality necessary to improve HbA1c. 
The CMS’ AHC model, which seeks to test linkage interventions to improve health, 
acknowledges the important role of the resource landscape.3 In the AHC’s ‘Track 3’—
Engagement—CMS calls upon healthcare delivery organizations to partner with social 
service providers in the same community in order to help tailor the resources available both 
to meet basic resource needs and to improve health.3
An important strength of this study is its pragmatic design. Compared with a highly selected 
population in a randomized-controlled trial, this study evaluated program operation in ‘real-
world’ conditions, and with the intention-to-treat analytic approach, the estimates of effects 
are likely generalizable to other primary-care settings serving populations that are 
underrepresented in randomized control trials. We should note, however, that clinic-based 
interventions such as this one do not reach those who are out of care. Although participants 
chose whether to enroll in the program after screening, we do not believe that differences in 
engagement with care or self-efficacy among those who enrolled are likely to have 
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influenced improvement in the study outcomes. The difference-in-difference design helps 
account for these unmeasured differences in participant characteristics by comparing 
participants to their own pre-intervention results. Further, the lack of benefit observed with 
regard to HbA1c suggests enrollment is not synonymous with improvement. However, 
without randomization it is impossible to exclude these differences as possible contributors 
to the findings observed. Finally, because program entry was not predicated on having 
elevated values of the study outcomes, but rather on unmet needs, regression to the mean is 
unlikely to explain the observed differences between the groups.
Despite these strengths, the results of this study should be interpreted in the light of several 
limitations. First, the three practices in this study already had advanced population health 
management programs that focused on blood pressure, cholesterol, and HbA1c. How these 
results would generalize to practices without such programs is unclear; it is possible that 
other settings could see larger reductions. Nevertheless, the results help understand what can 
be gained by adding programs that address unmet basic needs to current chronic disease 
management efforts. Second, the study was set in Massachusetts, where health insurance 
coverage is high.38 However, because national health insurance rates are, after the 
implementation of the Affordable Care Act, rising to the level of Massachusetts, the results 
are likely relevant in many settings.38 Other limitations include lack of information on those 
who did not complete screening, lack of information on duration of diabetes and tobacco 
use, and that the study analyst was not blinded to the exposure groups.
This study has several implications for the future study and use of linkage interventions. 
First, the “rapid resource referral” used in this study is similar to what is proposed in Track 1 
of the AHC model, and did not show benefit.3 Second, because 40% of our participants 
reporting unmet needs had commercial insurance, linkage programs may be worthwhile in a 
broad array of clinical settings. It will be important to determine whether linkage programs 
can be combined with ongoing population management efforts, such as identifying patients 
overdue for visits or not meeting clinical goals. Additionally, future work should focus on 
improvements to the program that may increase the benefits seen, and increase the 
conversion rate between those reporting needs and ultimate linkage to resources. 
Additionally, studies of linkage interventions incorporating randomized designs, particularly 
with cluster-randomization above the level of the participant (in order to include a more 
‘real-world’ selection of participants compared with participant-level randomization), would 
provide important complementary information. Finally, while this study focused on 
indicators of cardiometabolic control, there are several other potentially important outcomes 
for a linkage intervention that should be considered when evaluating its impact. Health 
related quality of life, reduction in stress and depressive symptoms, along with other 
indicators of mental well being, engagement with care, and the cost-effectiveness of the 
intervention are all important areas for future studies to investigate.
Conclusion
An intervention program that screens for unmet basic needs and attempts to link patients 
with these needs to community resources improved blood pressure and LDL-cholesterol, but 
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not HbA1c. Further refinement of these types of interventions, and their dissemination, 
holds promise for improving the health of vulnerable populations.
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Change from pre-intervention to post-intervention, with error bars, comparing those who 
screened positive to those who screened negative for unmet needs, for systolic blood 
pressure (upper left), diastolic blood pressure (upper right), low density lipoprotein 
cholesterol (lower left) and hemoglobin A1c (lower right).
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Table 1
Patient characteristics
Screened Negative for Unmet Needs
N=3351
Screened Positive for Unmet Needs*
N=1774
Age, years (SD) 56.7 (16.2) 57.6 (15.5)
Female (%) 56.5 55.7
Race/Ethnicity
 Non-Hispanic white (%) 85.9 53.2
 Non-Hispanic black (%) 5.0 23.5
 Hispanic (%) 3.2 13.7
 Asian/Multi/Other (%) 5.9 9.6
Insurance
 Commercial (%) 64.1 38.2
 Medicare (%) 27.4 38.0
 Medicaid (%) 4.3 15.5
 Self-pay (%) 4.3 8.4
≤High School Diploma Education 22.1 58.3
Non-English Primary Language (%) 8.3 23.8
Charlson Score (SD) 3.1 (2.4) 4.0 (2.9)
Cardiometabolic disease groups
 Hypertension 34.8 46.9
 Indication for LDL lowering 39.2 54.5
 Diabetes 9.6 25.5
Program Enrollment Status
 Enrolled -- 57.6
 Declined Referral -- 14.6
 Declined Services After Initial Interview -- 18.6
 Rapid Resource Referral -- 9.2
LDL = Low Density Lipoprotein Cholesterol
*
Considered the intervention group for main, intention-to-treat, analyses
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